Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies
Bianzano, Susanna, Henrich, Andrea, Herich, Lena, Kalsch, Brigitte, Sarubbi, Donald, Seitz, Friedeborg, Forst, Thomas
Published in Metabolism, clinical and experimental (01.06.2023)
Published in Metabolism, clinical and experimental (01.06.2023)
Get full text
Journal Article
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low-dose liraglutide in otherwise healthy men with overweight or obesity
Beetz, Nadine, Kalsch, Brigitte, Forst, Thomas, Schmid, Bernhard, Schultz, Armin, Hennige, Anita M
Published in Diabetes, obesity & metabolism (07.10.2024)
Published in Diabetes, obesity & metabolism (07.10.2024)
Get full text
Journal Article
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)
Meinertz, Thomas, Lip, Gregory Y.H, Lombardi, Fedrico, Sadowski, Zigmunt P, Kalsch, Brigitte, Camez, Anne, Hewkin, Ann, Eberle, Siegfried
Published in The American journal of cardiology (15.12.2002)
Published in The American journal of cardiology (15.12.2002)
Get full text
Journal Article